Selexis is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative biologic medicines and vaccines

Cooperation possibilities

Working with global clients, Selexis offers contract development and maintenance of high-performance mammalian cell lines used in the expression of pharmaceutically relevant proteins (i.e. membrane receptors, MAbs, plasma proteins, rProteins in general). Selexis has interactive partnerships for cell line development with some of the world's leading biotech, pharma and CMO companies.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2001
  • Number of employees in Switzerland
    20-49